A Review of Pathologic Myopia
- PMID: 36155945
- DOI: 10.1097/ICL.0000000000000917
A Review of Pathologic Myopia
Abstract
Pathologic myopia is a leading cause of vision loss worldwide and is most prevalent in developed nations in East and Southeast Asia. Although the pathophysiologic mechanisms behind pathologic myopia have yet to be elucidated, the process is thought to stem from excessive axial elongation of the globe and subsequent degeneration of vital structures within the posterior segment. The array of complications that arise from this condition can lead to significant visual impairment. The purpose of this article is to review the classification, pathophysiology, complications, and management of pathologic myopia.
Copyright © 2022 Contact Lens Association of Ophthalmologists.
Conflict of interest statement
J. J. K.: Sanofi. The remaining authors have no funding or conflicts of interest to disclose.
References
-
- Morgan IG, He M, Rose KA. Epidemic of pathologic myopia: What can laboratory studies and epidemiology tell us? Retina 2017;37:989–997.
-
- Holy C, Kulkarni K, Brennan NA. Predicting costs and disability from the myopia epidemic—a worldwide economic and social model. Invest Ophthalmol Vis Sci 2019;60:5466.
-
- Holden BA, Fricke TR, Wilson DA, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology 2016;123:1036–1042.
-
- Flitcroft DI, He M, Jonas JB, et al. IMI—defining and classifying myopia: A proposed set of standards for clinical and epidemiologic studies. Invest Ophthalmol Vis Sci 2019;60:M20–M30.
-
- Ikuno Y, Ohji M. High myopia and the vitreoretinal complications. Retina 2013;3:1912–1919.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
